This inventor holds 1 USPTO granted patent. Top assignee: Munin Corporation. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Innovations of Jeffrey A. Greenspan: Pioneering ECM Signaling Molecules
Introduction
Jeffrey A. Greenspan, an innovative inventor based in Chicago, IL, is making significant strides in the field of molecular biology. His pioneering research has led to the development of groundbreaking compositions and methods that have implications in various complex biological processes, including angiogenesis, chondrogenesis, and oncogenesis.
Latest Patents
Greenspan holds a notable patent titled "CYR61 Compositions and Methods," which focuses on polynucleotides encoding mammalian extracellular matrix (ECM) signaling molecules. These molecules play critical roles in cell adhesion, migration, and proliferation. His patent describes various compositions, including DNAs and RNAs that comprise portions or all of an ECM signaling molecule coding sequence. Additionally, the patent outlines polypeptide compositions that consist of mammalian ECM signaling molecules, peptide fragments, and inhibitory peptides. Moreover, it details methods for producing mammalian ECM signaling molecules and applications for screening and modulating conditions associated with their activities.
Career Highlights
In his professional journey, Jeffrey Greenspan has contributed to the advancement of scientific knowledge and technology through his work at Munin Corporation. His research has positioned him as a reputable figure in his field, especially given the innovative nature of his patent. The insights garnered from his work not only demonstrate his prowess as an inventor but also highlight the potential applications of his discoveries in medical therapies and diagnostics.
Collaborations
Throughout his career, Greenspan has collaborated with esteemed colleagues such as Lester F. Lau and Cho-Yau Yeung. These partnerships illustrate the collaborative spirit that often propels scientific innovation, as researchers pool their expertise to tackle complex biological challenges.
Conclusion
Jeffrey A. Greenspan stands out as a dedicated inventor whose contributions to the understanding of ECM signaling molecules could have lasting impacts on medical research and applications. His patented work offers valuable insights into cell behavior, which could eventually lead to breakthroughs in treating various health conditions. As innovations continue to emerge from his research, Greenspan's legacy in the field of molecular biology is poised to grow further.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile